Skip to main content
. 2022 Feb 24;23:178. doi: 10.1186/s13063-022-06086-2

Table 1.

The schedule of enrollment, interventions, and assessments

Workflow Enrollment Allocation Follow-up Close-out
− 7 days Day 0 Day 1 Day 7 Day 14 Day 30 Day 60 Day 90
Enrollment
Eligibility screening
Informed consent
Allocation
Interventions
FMT capsules
Placebo capsules
Assessments
Comorbid diseases and treatment
Physical examination
Office BP and heart rate
24-h ABPM
Blood routine
Urine routine
Blood chemical test
Urine microalbumin, creatinine
ECG
Arterial stiffness (ABI, PWV)
Diet records
Patient compliance
Adverse events
Combined medications for accompanied diseases
Fecal sample collection
Blood sample collection

Blood biochemical test: ALT alanine aminotransferase, AST aspartate aminotransferase, K potassium, Na sodium, Cl chloride, BUN urea nitrogen, CREA creatinine, UA uric acid, TC total cholesterol, TG triglyceride, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, GLU fasting blood glucose